NRAS and neoplasm: Together, these reports support the results of Echevarría‐Vargas et al (2018), which TCF19 plays a crucial role in BET/MEK inhibitor‐mediated blockage of tumor growth in NRAS‐mutant melanoma cells by perturbing the cell cycle machinery and activating apoptotic signaling.